CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823562771
- Phone
- (650) 457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $111,656
- in 2 filings
Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 47 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-22 | WITTE OWEN N. Director | Sale | −10,000 | $11.76 | $118K | 233,271 |
| 2022-06-21 | Amado Rafael EVP of R&D and CMO | Sale | −2,000 | $11.18 | $22K | 544,257 |
| 2022-06-15 | Humer Franz B Director | Grant or award | +44,178 | 191,892 | ||
| 2022-06-15 | SATO VICKI L Director | Grant or award | +22,089 | 41,451 | ||
| 2022-06-15 | SATO VICKI L Director | Grant or award · Stock Option (Right to Buy) | +35,535 | $9.62 | $342K | 35,535 |
| 2022-06-15 | Kazam Joshua A Director | Grant or award | +44,178 | 303,063 | ||
| 2022-06-15 | WITTE OWEN N. Director | Grant or award | +22,089 | 243,271 | ||
| 2022-06-15 | WITTE OWEN N. Director | Grant or award · Stock Option (Right to Buy) | +35,535 | 35,535 | ||
| 2022-06-15 | Barrett Elizabeth A. Director | Grant or award · Stock Option (Right to Buy) | +71,070 | 71,070 | ||
| 2022-06-15 | MESSEMER DEBORAH M. Director | Grant or award · Stock Option (Right to Buy) | +71,070 | 71,070 | ||
| 2022-05-19 | Amado Rafael EVP of R&D and CMO | Sale | −11,500 | $7.40 | $85K | 546,257 |
| 2022-03-31 | PF Equity Holdings 2 B.V. 10% owner | Other disposition | −22,032,040 | 0 | ||
| 2022-03-23 | Amado Rafael EVP of R&D and CMO | Grant or award | +237,358 | 557,477 | ||
| 2022-03-23 | Amado Rafael EVP of R&D and CMO | Grant or award · Stock Option (Right to Buy) | +368,589 | 368,589 | ||
| 2022-03-23 | Chang David D President and CEO | Grant or award · Stock Option (Right to Buy) | +2,195,512 | 2,195,512 | ||
| 2022-03-23 | MOORE ALISON Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +737,179 | 737,179 | ||
| 2022-03-23 | Belldegrun Arie Director | Grant or award · Stock Option (Right to Buy) | +1,458,333 | 1,458,333 | ||
| 2022-03-23 | SCHMIDT ERIC THOMAS Chief Financial Officer | Grant or award | +237,358 | 337,904 | ||
| 2022-03-23 | SCHMIDT ERIC THOMAS Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +368,589 | 368,589 | ||
| 2022-03-23 | Bhavnagri Veer General Counsel | Grant or award | +175,438 | 589,279 |
Page 9 of 18 · 348 trades